Lebwohl, Mark, Andrew Blauvelt, Alan Menter, Kim Papp, and Abby Jacobson. “Long-Term Efficacy, Safety, and Patient-Reported Outcomes in a Phase 2 Study of Brodalumab”. SKIN The Journal of Cutaneous Medicine 3 (November 9, 2019): S26. Accessed July 3, 2024. https://jofskin.org/33014/index.php/skin/article/view/753.